Cerebrospinal Fluid Neuropeptide Y Levels in Major Depression and Reported Childhood Trauma

被引:18
作者
Soleimani, Laili [1 ]
Oquendo, Maria A. [2 ,3 ]
Sullivan, Gregory M. [2 ,3 ]
Mathe, Aleksander A. [5 ]
Mann, J. John [2 ,3 ,4 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA
[2] New York State Psychiat Inst & Hosp, Div Mol Imaging & Neuropathol, New York, NY 10032 USA
[3] Columbia Univ, Dept 3Psychiat, New York, NY USA
[4] Columbia Univ, Dept Radiol, New York, NY USA
[5] Karolinska Inst, Div Psychiat, Stockholm, Sweden
基金
英国医学研究理事会;
关键词
childhood trauma; CSF; major depression; neuropeptide Y; CORTICOTROPIN-RELEASING HORMONE; RAT-BRAIN; CSF; SCHIZOPHRENIA; DISORDERS; SEROTONIN; ANXIETY; EXPRESSION; STRESS; CORTEX;
D O I
10.1093/ijnp/pyu023
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Neuropeptide Y (NPY) may enhance resilience to chronic stress. Low brain NPY reported in major depression may normalize in response to antidepressants. Methods: In this study, we examined the relationship of reported childhood trauma to cerebrospinal fluid (CSF) NPY-like immunoreactivity (NPY-LI) in 61 medication-free major depressive disorder (MDD) patients and 20 matched healthy volunteers. Results: Higher CSF NPY-LI was found in MDD compared to the healthy volunteer group (p = 0.01). A positive correlation of CSF NPY-LI with more adverse childhood trauma (p = 0.001) may be indicative of an intact but insufficient NPY-related stress response. Conclusions: We hypothesize that differences in published results may be explained by the existence of two groups of MDD in terms of CSF NPY levels: MDD with low CSF NPY prior to stress or in response to stress, and those with robust NPY responses to stress. Future studies should confirm the two groups and seek the molecular mechanism for their differences.
引用
收藏
页数:6
相关论文
共 35 条
  • [1] [Anonymous], 1998, STRUCTURED CLIN INTE
  • [2] Neuronal tryptophan hydroxylase expression in BALB/cJ and C57Bl/6J mice
    Bach, Helene
    Arango, Victoria
    Huang, Yung-Yu
    Leong, Sharlene
    Mann, J. John
    Underwood, Mark D.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2011, 118 (06) : 1067 - 1074
  • [3] Characterization of cerebrospinal fluid (CSF) and plasma NPY levels in normal volunteers over a 24-h timeframe
    Baker, Dewleen G.
    Bertram, Tobias Moeller
    Patel, Piyush M.
    Barkauskas, Donald A.
    Clopton, Paul
    Patel, Sejal
    Geracioti, Thomas D., Jr.
    Haji, Uzair
    O'Connor, Daniel T.
    Nievergelt, Caroline M.
    Hauger, Richard L.
    [J]. PSYCHONEUROENDOCRINOLOGY, 2013, 38 (10) : 2378 - 2382
  • [4] INITIAL RELIABILITY AND VALIDITY OF A NEW RETROSPECTIVE MEASURE OF CHILD-ABUSE AND NEGLECT
    BERNSTEIN, DP
    FINK, L
    HANDELSMAN, L
    FOOTE, J
    LOVEJOY, M
    WENZEL, K
    SAPARETO, E
    RUGGIERO, J
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1994, 151 (08) : 1132 - 1136
  • [5] CEREBROSPINAL-FLUID NEUROPEPTIDE-Y IN DEPRESSION AND SCHIZOPHRENIA
    BERRETTINI, WH
    DORAN, AR
    KELSOE, J
    ROY, A
    PICKAR, D
    [J]. NEUROPSYCHOPHARMACOLOGY, 1987, 1 (01) : 81 - 83
  • [6] BROQUA P, 1995, BEHAV PHARMACOL, V6, P215
  • [7] Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder
    Caberlotto, L
    Hurd, YL
    [J]. NEUROREPORT, 1999, 10 (08) : 1747 - 1750
  • [8] The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype:: evidence from the Spanish PREDICT-Gene cohort
    Cervilla, J. A.
    Molina, E.
    Rivera, M.
    Torres-Gonzalez, F.
    Bellon, J. A.
    Moreno, B.
    Luna, J. D.
    Lorente, J. A.
    Mayoral, F.
    King, M.
    Nazareth, I.
    Gutierrez, B.
    [J]. MOLECULAR PSYCHIATRY, 2007, 12 (08) : 748 - 755
  • [9] The Neuropeptide Y (NPY)-ergic System is Associated with Behavioral Resilience to Stress Exposure in an Animal Model of Post-Traumatic Stress Disorder
    Cohen, Hagit
    Liu, Tianmin
    Kozlovsky, Nitsan
    Kaplan, Zeev
    Zohar, Joseph
    Mathe, Aleksander A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2012, 37 (02) : 350 - 363
  • [10] Collier DA, 1996, MOL PSYCHIATR, V1, P453